Voyager Therapeutics to Present at the Evercore ISI Healthcare Conference
November 19 2018 - 4:21PM
Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene
therapy company focused on developing life-changing treatments for
severe neurological diseases today announced management’s
presentation at the upcoming investor conference:
- Evercore ISI Healthcare Conference,
BostonDate: Tuesday, November 27,
2018Presentation Time: 7:30 a.m.
ESTPresenter: Dinah Sah, Ph.D., chief scientific
officer
Live-streaming webcasts of these presentations
can be accessed through the Investors & Media section of
Voyager’s website at www.voyagertherapeutics.com. The webcast
will be archived for 30 days after the live event concludes.
About Voyager Therapeutics
Voyager Therapeutics is a clinical-stage gene
therapy company focused on developing life-changing treatments for
severe neurological diseases. Voyager is committed to advancing the
field of AAV gene therapy through innovation and investment in
vector engineering and optimization, manufacturing and dosing and
delivery techniques. Voyager’s pipeline focuses on severe
neurological diseases in need of effective new therapies, including
Parkinson’s disease, a monogenic form of ALS called SOD1,
Huntington’s disease, Friedreich’s ataxia, neurodegenerative
diseases related to defective or excess aggregation of tau protein
in the brain including Alzheimer’s disease and severe, chronic
pain. Voyager has broad strategic collaborations with Sanofi
Genzyme, the specialty care global business unit of Sanofi, AbbVie,
and the University of Massachusetts Medical School. Founded
by scientific and clinical leaders in the fields of AAV gene
therapy, expressed RNA interference and neuroscience, Voyager
Therapeutics is headquartered in Cambridge, Massachusetts.
Investor Relations:
Matt Osborne
Vice President of Investor Relations & Corporate Communications
857-259-5353
mosborne@vygr.com
Media:
Sheryl Seapy
W2O Group
949-903-4750
sseapy@w2ogroup.com
Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart
From Apr 2023 to Apr 2024